Nicholas Opalich, a distinguished figure in the pharmacy sector, has carved out a remarkable career over more than 25 years, predominantly in Northeast Ohio. Renowned for his expertise in mergers and acquisitions, he has significantly contributed to the pharmacy industry, holding pivotal roles in various pharmaceutical-related fields.
Nick's career trajectory has seen him excel in executive roles across multiple domains. He has a rich background in hospice pharmaceutical claims processing, pharmacy benefits, and collaborating with drug manufacturers. His notable expertise lies in hospice and palliative care pharmacy operations. Additionally, he has demonstrated proficiency in mail-order pharmacy systems, specialty infusion services, pharmaceutical procurement models, and medication distribution channels. Under his guidance, several companies have achieved impressive valuations.
Moreover, he has played a mentorship role in various aspects of the industry, including hospice pharmacy operations, specialty medical benefit management, and business development. He has also been influential in areas like account management, call center systems, product design management, marketing, and corporate business workflow processes.
An alumnus of David N. Myers University in Cleveland, Ohio, Opalich holds bachelor's degrees in both pharmacy and business management. Beyond his professional endeavors, he is dedicated to philanthropy and volunteering, supporting causes like animal welfare, poverty alleviation, public health, and homeless shelters. His interests include family time, football, sailing, and wrestling.
In his current role, he is the Founder and CEO of HospiceChoice Rx, a company specializing in pharmacy benefits management for hospice care, which commenced operations in 2023. HospiceChoice Rx is now actively engaging with several major hospice providers, emphasizing patient care and comfort in its service model.
Earlier in his career, Nicholas established OPSIA and OPSIC, playing critical roles in their growth and navigating changes in the healthcare landscape. Under his leadership, OPSIA acquired OPSIC, later evolving into Continental Healthcare, Inc. This transformation marked a significant milestone, establishing the company as a major distributor and pharmacy for notable drug companies.
In 2002, Nick Opalich founded Strategica Health Partners, a healthcare services and pharmaceutical consultancy firm. As CEO, he guided the firm through various stages of development, growth, and productivity, managing critical engagements with several well-known clients. He concluded his tenure as CEO in 2013 but remains a managing partner. His leadership at Strategica was instrumental in its success and expansion in the healthcare and pharmaceutical sectors.
Portfolio Website:
https://nicholasopalich.com
https://nicholasopalichceo.com
